GLP-1 receptor agonists influence multiple biological pathways that extend beyond glucose metabolism
The most frequently reported side effects in this study were mild to moderate nausea, diarrhea, vomiting, and constipation
The success of clinical trials with exenatide and liraglutide sparked growing interest in therapies based on GLP-1
It is likely better for those who are trying to achieve smaller goals, where their goal is to lose 5-10 pounds
Dehydration is a risk with empagliflozin due to increased urination
White adipose tissue remodeling Jing Yi Zhao, Li Juan Zhou, Kai Le Ma, Rui Hao, Min Li Obesity Reviews.2024;[Epub] CrossRef Resistin in endocrine pancreas of sheep: Presence and expression related to different diets Margherita Maranesi, Elisa Palmioli, Cecilia Dall'Aglio, Daniele Marini, Polina Anipchenko, Elena De Felice, Paola Scocco, Francesca Mercati General and Comparative Endocrinology.2024